What question did this study set out to answer?

The study examines the cost-effectiveness of a digital self-management program for symptoms of inflammatory bowel disease.

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial assesses cost-effectiveness of IBD-BOOST intervention for pain and fatigue in IBD, suggesting its economic advantage.

The study examines the cost-effectiveness of a digital self-management program for symptoms of inflammatory bowel disease.
Cost-effectiveness analysis was performed alongside the IBD-BOOST trial.
Participants were randomized to IBD-BOOST (N=391) or usual care (N=389) over 12 months.
Health services use and costs were measured, including quality-adjusted life years (QALYs) at multiple follow-ups.
IBD-BOOST intervention achieved an increase of 0.016 QALYs (95% CI 0.002 to 0.030) over 12 months.
Cost savings of −£304.66 for healthcare and −£39.48 for out-of-pocket costs were recorded.
Cost-effectiveness was high, with savings of −£28 633 and −£33 568 per QALY gained from healthcare and societal perspectives.

Roukas et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark